Research on the construction of an AI diagnostic model for plus disease of retinopathy of prematurity based on cross-center fusion datasets

基于跨中心融合数据集的早产儿视网膜病变+期疾病人工智能诊断模型构建研究

阅读:4

Abstract

PURPOSE: Retinopathy of prematurity (ROP) is a leading cause of blindness in infants. Early and accurate screening is essential. Current deep learning systems can help, yet their accuracy drops when used on different population. We aimed to find the best deep learning model for plus disease in ROP and to test it on a multi-center dataset. METHODS: We built a cross-center retinal image database by merging public and private sets (FARFUM-RoP, HVDROPDB, LAN-RoP, Preterm infants <34 weeks GA from three tertiary NICUs, 2635 images). Nine types models were compared: ResNet34, ResNet50, DenseNet, Inception, MobileNet, VGG16, VGG19, EfficientNet, and Swin-Transformer. We compared FLOPs, parameter count, accuracy, recall, precision, and F1 score. ResNet50 showed the best balance and was kept. Ten-fold cross-validation was run on FARFUM-RoP alone, LAN-RoP alone, and their combined set. RESULTS: Across the three diagnostic tasks, the ResNet50 algorithm attained area-under-the-curve (AUC) values of 0.97, 0.95 and 1.00 (95% CI 0.94-0.99, 0.91-0.98, 0.97-1.00) for Normal, Pre-plus and Plus disease, respectively. When trained on the consolidated multi-centre cohort, the model achieved optimal overall performance, delivering an accuracy of 92.60%, recall of 92.58%, precision of 92.69% and F1-score of 92.60%-all metrics surpassing those obtained with any single-centre training set. CONCLUSION: Compared with single-centre training, the cross-centre fusion strategy significantly enhanced the generalisability of the artificial-intelligence model, yielded superior diagnostic indices, and improved diagnostic accuracy for infants from diverse demographic backgrounds.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。